Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

COGTCOGT
23 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in Cogent Biosciences, Inc.

CITADEL ADVISORS LLC holds 849,694 shares of COGT (Cogent Biosciences, Inc.), worth $32.9M as of 2026-Q2. The position was decreased (-50.5% shares). COGT represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$32.9M

Current Shares

849,694

Total Value Change

+$23.3M

Total Shares Change

-7,248

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
849,694
-50.5%
$32.9M0.0%$38.70
0
2026-Q1
Increased
1.7M
+19.2%
$66M0.0%$37.24
35
2025-Q4
Decreased
1.4M
-13.7%
$51.1M0.0%$37.12
0
2025-Q3
Increased
1.7M
+168.5%
$23.9M0.0%$14.13
46
2025-Q2
Increased
621,235
+26.9%
$4.5M0.0%$7.10
33
2025-Q1
Increased
489,688
+401.4%
$2.9M0.0%$6.48
42
2024-Q4
Increased
97,663
+912.4%
$761,7710.0%$7.71
40
2024-Q3
Increased
9,647
+6.7%
$104,1880.0%$10.90
16
2024-Q2
Decreased
9,044
-93.1%
$76,2410.0%$8.43
0
2024-Q1
Decreased
131,891
-79.4%
$886,3080.0%$6.72
0
2023-Q4
Increased
640,771
+957.3%
$3.8M0.0%$5.88
43
2023-Q3
Decreased
60,605
-55.0%
$590,8990.0%$9.75
0
2023-Q2
Decreased
134,767
-89.6%
$1.6M0.0%$11.57
0
2023-Q1
Decreased
1.3M
-30.1%
$14M0.0%$10.43
0
2022-Q4
Increased
1.9M
+39.2%
$21.4M0.0%$11.56
38
2022-Q3
Increased
1.3M
+24.3%
$19.9M0.0%$14.40
35
2022-Q2
Increased
1.1M
+1535.9%
$9.7M0.0%$8.87
45
2022-Q1
New
65,501
-
$491,0000.0%$7.52
33
2021-Q4
Exited
0
-100.0%
$00.0%$8.56
0
2021-Q3
New
14,340
-
$121,0000.0%$8.38
34
2021-Q2
Exited
0
-100.0%
$00.0%$8.02
0
2021-Q1
Increased
1.3M
+52.1%
$11.1M0.0%$8.34
39
2020-Q4
New
856,942
-
$9.6M0.0%$11.41
38

Other major holders of COGT: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used